Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIECE: perioperative chemotherapy with adjuvant S-1 for resectable esophageal cancer
jRCTs051180154Phase 2Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur in esophageal cancer, sponsored by Taiho Pharmaceutical Co., Ltd. Primary endpoint: Three-year relapse-free survival. Started Jan 2016; status: completed.
02
Drugs
tegafur
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on jRCTs051180154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180154.